Abstract
BACKGROUND: Immune-related hepatitis is one of the prevalent adverse events associated with immunotherapy, especially im-mune checkpoint inhibitors (I......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
